LA Times on the vaccine market

This morning's Los Angeles Times ran an editorial on the state of the vaccine industry in light of Pfizer's acquisition of PowderMed:

Two years ago, the closure of one British vaccine plant wreaked havoc on the world's ability to respond to the flu. The investments by Pfizer and others show how market forces, in concert with the nonprofit and public sectors, can work in the public interest